Return On Equity of Immunovant, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immunovant, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Immunovant, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -85%, a 51% decline year-over-year.
  • Immunovant, Inc. annual Return On Equity for 2024 was -90%, a 39% decline from 2023.
  • Immunovant, Inc. annual Return On Equity for 2023 was -64%, a 43% decline from 2022.
  • Immunovant, Inc. annual Return On Equity for 2022 was -45%, a 8.4% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Immunovant, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -85% -29% -51% 01 Jul 2025 30 Sep 2025
Q2 2025 -84% -32% -62% 01 Apr 2025 30 Jun 2025
Q1 2025 -81% -24% -44% 01 Jan 2025 31 Mar 2025
Q4 2024 -78% -17% -28% 01 Oct 2024 31 Dec 2024
Q3 2024 -56% +20% +27% 01 Jul 2024 30 Sep 2024
Q2 2024 -52% +14% +22% 01 Apr 2024 30 Jun 2024
Q1 2024 -56% -4% -7% 01 Jan 2024 31 Mar 2024
Q4 2023 -61% -15% -32% 01 Oct 2023 31 Dec 2023
Q3 2023 -77% -38% -96% 01 Jul 2023 30 Sep 2023
Q2 2023 -66% -32% -94% 01 Apr 2023 30 Jun 2023
Q1 2023 -52% -19% -57% 01 Jan 2023 31 Mar 2023
Q4 2022 -46% -16% -51% 01 Oct 2022 31 Dec 2022
Q3 2022 -39% -9% -30% 01 Jul 2022 30 Sep 2022
Q2 2022 -34% -7% -24% 01 Apr 2022 30 Jun 2022
Q1 2022 -33% -5% -18% 01 Jan 2022 31 Mar 2022
Q4 2021 -31% +2% +6.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% +5% +14% 01 Jul 2021 30 Sep 2021
Q2 2021 -28% +37% +57% 01 Apr 2021 30 Jun 2021
Q1 2021 -28% +127% +82% 01 Jan 2021 31 Mar 2021
Q4 2020 -33% +186% +85% 01 Oct 2020 31 Dec 2020
Q3 2020 -35% -899% -104% 01 Jul 2020 30 Sep 2020
Q2 2020 -65% +2493% +97% 01 Apr 2020 30 Jun 2020
Q1 2020 -156% -176% 01 Jan 2020 31 Mar 2020
Q4 2019 -219% 01 Oct 2019 31 Dec 2019
Q3 2019 864% 01 Jul 2019 30 Sep 2019
Q2 2019 -2558% 01 Apr 2019 30 Jun 2019
Q1 2019 20%* 01 Jan 2019 31 Mar 2019

Immunovant, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -90% -25% -39% 01 Apr 2024 31 Mar 2025
2023 -64% -20% -43% 01 Apr 2023 31 Mar 2024
2022 -45% -3% -8.4% 01 Apr 2022 31 Mar 2023
2021 -41% +211% +84% 01 Apr 2021 31 Mar 2022
2020 -252% -319% -473% 01 Apr 2020 31 Mar 2021
2019 68% 01 Apr 2019 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.